Skip to search formSkip to main contentSkip to account menu

1p/19q Codeletion

Known as: Loss of Chromosomes 1p/19q 
A chromosomal aberration where there is a loss of both the short arm of chromosome 1 and the long arm of chromosome 19. This chromosomal aberration… 
National Institutes of Health

Related topics

Related topics

3 relations
Chromosomes, Human, Pair 1Chromosomes, Human, Pair 19Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
OBJECTIVE With the revised WHO 2016 classification of brain tumors, there has been increasing interest in imaging biomarkers to… 
2019
2019
PL3.3 Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion
The 1st interim analysis of the CATNON trial showed benefit from adjuvant (adj) temozolomide (TMZ) on overall survival (OS… 
2016
2016
Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors
Currently, oligodendroglial tumours (OT) are routinely tested for 1p/19q codeletion, a genetic abnormality of prognostic value… 
2015
2015
Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status
The aim of this study was to assess whether combining multimodal magnetic resonance imaging (MRI) with the determination of the… 
2015
2015
p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma.
2015
2015
Radiotherapy in relation to temozolomide: Subgroup analysis of molecular markers of the randomized phase III study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) in patients with a high risk…
2006 Background: A subgroup analysis based on molecular markers of patients randomized between standard radiotherapy (RT) and… 
2014
2014
Rhabdoid glioblastoma is distinguishable from classical glioblastoma by cytogenetics and molecular genetics.
2013
2013
Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors
Oligodendroglial tumors (OTs) are primary brain tumors that show variable clinical and biological behavior. The 1p/19q codeletion… 
2013
2013
Is there pseudoprogression in secondary glioblastomas?
2011
2011
&agr;-Internexin in the Diagnosis of Oligodendroglial Tumors and Association With 1p/19q Status
&agr;-Internexin (INA) has been proposed to be a surrogate marker for the 1p/19q codeletion in oligodendroglial tumors (OTs). We… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)